Nexus Surgical and Medicare Limited

BSE:538874 Stock Report

Market Cap: ₹99.0m

Nexus Surgical and Medicare Valuation

Is 538874 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 538874 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 538874's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 538874's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 538874?

Key metric: As 538874 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 538874. This is calculated by dividing 538874's market cap by their current earnings.
What is 538874's PE Ratio?
PE Ratio24.8x
Earnings₹4.00m
Market Cap₹98.99m

Price to Earnings Ratio vs Peers

How does 538874's PE Ratio compare to its peers?

The above table shows the PE ratio for 538874 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average38.6x
543594 Dipna Pharmachem
15xn/a₹162.3m
SAROJA Saroja Pharma Industries India
32.7xn/a₹233.0m
530697 Zenlabs Ethica
73.7xn/a₹262.4m
542934 Chandra Bhagat Pharma
32.9xn/a₹520.6m
538874 Nexus Surgical and Medicare
24.8xn/a₹99.0m

Price-To-Earnings vs Peers: 538874 is good value based on its Price-To-Earnings Ratio (24.8x) compared to the peer average (38.6x).

Price to Earnings Ratio vs Industry

How does 538874's PE Ratio compare vs other companies in the IN Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.1xn/aUS$11.88m
542918 Gian Life Care
4.8xn/aUS$2.32m
No more companies available in this PE range
538874 24.8xIndustry Avg. 42.6xNo. of Companies6PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 538874 is good value based on its Price-To-Earnings Ratio (24.8x) compared to the Indian Healthcare industry average (42.6x).

Price to Earnings Ratio vs Fair Ratio

What is 538874's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

538874 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio24.8x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 538874's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Medico Intercontinental

₹557.2m

Trades in pharmaceutical products.

539938

₹61.29

7D

33.1%

1Y

-27.8%

Dr Lalchandani Labs

₹81.2m

Provides diagnostic and related healthcare tests and services in India.

541299

₹18.73

7D

4.1%

1Y

-46.5%

N G Industries

₹566.9m

Provides various healthcare services in India.

530897

₹168.05

7D

0.2%

1Y

2.7%